Marker Therapeutics' GAAP loss for 6M 2021 was $19.686 million, up 53.5% from $12.827 million in the prior year.
Marker Therapeutics' GAAP loss for 6M 2021 was $19.686 million, up 53.5% from $12.827 million in the prior year.
Financial results
Marker Therapeutics' GAAP loss for 6M 2021 was $19.686 million, up 53.5% from $12.827 million in the prior year. Source: 
ir.markertherapeutics.com
ir.markertherapeutics.com
English (US) 